These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11689781)

  • 1. Hepatitis B and C in the liver transplant recipient: current understanding and treatment.
    Rosen HR
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S87-98. PubMed ID: 11689781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C in the liver transplant recipient.
    Rosen HR; Martin P
    Semin Liver Dis; 2000; 20(4):465-80. PubMed ID: 11200416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis B and C following liver transplantation.
    Sponseller CA; Ramrakhiani S
    Curr Gastroenterol Rep; 2002 Feb; 4(1):52-62. PubMed ID: 11825542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver transplantation in patients with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus].
    Duclos-Vallée JC; Roche B; Samuel D
    Presse Med; 2009 Sep; 38(9):1281-9. PubMed ID: 19574023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.
    Manzia TM; Di Paolo D; Sforza D; Toti L; Angelico R; Brega A; Angelico M; Tisone G
    Transplant Proc; 2010 May; 42(4):1200-3. PubMed ID: 20534261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in virus-induced chronic liver disease.
    Colantoni A; De Maria N; Fagiuoli S; Van Thiel DH
    Baillieres Clin Gastroenterol; 1996 Jul; 10(2):375-88. PubMed ID: 8864038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in viral hepatitis: prevention of recurrence.
    Roche B; Samuel D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B: progress in the last 15 years.
    Villamil FG
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S59-66. PubMed ID: 12362301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis and liver transplantation.
    Sharma P; Lok A
    Semin Liver Dis; 2006 Aug; 26(3):285-97. PubMed ID: 16850378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
    Rosen HR; Gretch D; Kaufman E; Quan S
    Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
    Riediger C; Berberat PO; Sauer P; Gotthardt D; Weiss KH; Mehrabi A; Merle U; Stremmel W; Encke J
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii37-viii46. PubMed ID: 17890261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and hepatitis C viruses in liver transplantation.
    Curry MP
    Transplantation; 2004 Oct; 78(7):955-63. PubMed ID: 15480158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
    Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
    Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis in the liver transplant recipient.
    Rosen HR; Martin P
    Infect Dis Clin North Am; 2000 Sep; 14(3):761-84. PubMed ID: 10987119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses].
    Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
    Z Gastroenterol; 1992 Sep; 30(9):576-82. PubMed ID: 1449005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection.
    Perrakis A; Förtsch T; Del Medico A; Croner RS; Vassos N; Yedibela S; Lohmüller C; Zopf S; Hohenberger W; Müller V
    Transplant Proc; 2013 Jun; 45(5):1953-6. PubMed ID: 23769081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.